Is It Time for Costco to Split?
Costco’s stock price has experienced enormous growth over the last…
Sell
31
XRAY Quote, Financials, Valuation and Earnings
Last price:
$18.97
Seasonality move
:
1.53%
Day range:
$18.35 - $18.87
52-week range:
$17.21 - $37.60
Dividend yield:
3.43%
P/E ratio:
--
P/S ratio:
0.99x
P/B ratio:
1.49x
Volume:
2M
Avg. volume:
2.9M
1-year change:
-47.6%
Market cap:
$3.7B
Revenue:
$4B
EPS (TTM):
-$2.07
Analysts' Opinion
-
Consensus RatingDentsply Sirona has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.96, Dentsply Sirona has an estimated upside of 23.13% from its current price of $18.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $18.65.
Fair Value
-
According to the consensus of 12 analysts, Dentsply Sirona has 23.13% upside to fair value with a price target of $22.96 per share.
XRAY vs. S&P 500
-
Over the past 5 trading days, Dentsply Sirona has overperformed the S&P 500 by 2.84% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Dentsply Sirona does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Dentsply Sirona has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Dentsply Sirona reported revenues of $951M.
Earnings Growth
-
Dentsply Sirona has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Dentsply Sirona reported earnings per share of -$2.46.
Enterprise value:
5.6B
EV / Invested capital:
--
Price / LTM sales:
0.99x
EV / EBIT:
--
EV / Revenue:
1.44x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
15.42x
Price / Operating cash flow:
10.54x
Enterprise value / EBITDA:
89.32x
Gross Profit (TTM):
$2B
Return On Assets:
-5.86%
Net Income Margin (TTM):
-10.59%
Return On Equity:
-13.34%
Return On Invested Capital:
-7.95%
Operating Margin:
6.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $4B | $3.9B | $3.9B | $947M | $951M | |
| Gross Profit | $2.2B | $2.1B | $2B | $495M | $495M | |
| Operating Income | $470M | $279M | $248M | $76M | $64M | |
| EBITDA | -$514M | $198M | $63M | -$143M | -$371M | |
| Diluted EPS | -$3.88 | -$1.01 | -$2.07 | -$1.25 | -$2.46 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.6B | $1.8B | $1.9B | $1.9B | $1.9B | |
| Total Assets | $8.9B | $9.3B | $7.5B | $7.2B | $6.6B | |
| Current Liabilities | $1.2B | $1.1B | $1.3B | $1.2B | $1.5B | |
| Total Liabilities | $4.1B | $4.2B | $3.9B | $3.8B | $4.1B | |
| Total Equity | $4.8B | $5.1B | $3.6B | $3.4B | $2.5B | |
| Total Debt | $2.2B | $2.1B | $2B | $2B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $597M | $359M | $534M | $134M | $141M | |
| Cash From Investing | -$148M | -$98M | -$160M | -$2M | -$47M | |
| Cash From Financing | -$290M | -$340M | -$392M | -$109M | -$79M | |
| Free Cash Flow | $439M | $218M | $365M | $97M | $98M | |
XRAY
Sector
Market Cap
$3.7B
$46.3M
Price % of 52-Week High
49.6%
46%
Dividend Yield
3.43%
0%
Shareholder Yield
9.3%
-0.64%
1-Year Price Total Return
-47.6%
-33.33%
Beta (5-Year)
0.965
0.772
Dividend yield:
3.43%
Annualized payout:
$0.56
Payout ratio:
-30.27%
Growth streak:
5 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$18.81
200-day SMA
Sell
Level
$25.57
Bollinger Bands (100)
Sell
Level
19.72 - 25.8
Chaikin Money Flow
Buy
Level
256.1M
20-day SMA
Sell
Level
$19.25
Relative Strength Index (RSI14)
Sell
Level
40.09
ADX Line
Sell
Level
16.58
Williams %R
Buy
Level
-84.5771
50-day SMA
Sell
Level
$20.26
MACD (12, 26)
Sell
Level
-0.36
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
140.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.7096)
Sell
CA Score
(Annual)
Level (-0.4376)
Buy
Beneish M-Score
(Annual)
Level (-2.7543)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.3233)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm’s wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm’s salesforce or directly to consumers (such as Byte clear aligner).
Stock Forecast FAQ
In the current month, XRAY has received 4 Buy ratings 8 Hold ratings, and 0 Sell ratings. The XRAY average analyst price target in the past 3 months is $22.96.
-
Where Will Dentsply Sirona Stock Be In 1 Year?
According to analysts, the consensus estimate is that Dentsply Sirona share price will rise to $22.96 per share over the next 12 months.
-
What Do Analysts Say About Dentsply Sirona?
Analysts are divided on their view about Dentsply Sirona share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Dentsply Sirona is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is Dentsply Sirona's Price Target?
The price target for Dentsply Sirona over the next 1-year time period is forecast to be $22.96 according to 12 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is XRAY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Dentsply Sirona is a Hold. 8 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of XRAY?
You can purchase shares of Dentsply Sirona via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Dentsply Sirona shares.
-
What Is The Dentsply Sirona Share Price Today?
Dentsply Sirona was last trading at $18.97 per share. This represents the most recent stock quote for Dentsply Sirona. Yesterday, Dentsply Sirona closed at $18.65 per share.
-
How To Buy Dentsply Sirona Stock Online?
In order to purchase Dentsply Sirona stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FedEx’s Spinoff Boost Its Stock Price?
In a pre-holiday surprise announcement, management at FedEx (NYSE:FDX) released…
Why Is Buffett Buying Verisign?
Warren Buffett has spent 2024 stockpiling cash, even going so…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Buy
100
IPX alert for Dec 31
IperionX [IPX] is down 9.31% over the past day.
Buy
58
QMCO alert for Dec 31
Quantum [QMCO] is down 13.43% over the past day.
Buy
55
SMLR alert for Dec 31
Semler Scientific [SMLR] is down 4.39% over the past day.
